1. Identification and characterization of a tumor infiltrating CD56⁺/CD16⁻ NK cell subset with specificity for pancreatic and prostate cancer cell lines

   • Timothy L. Frankel
   • William Burns
   • Richard E. Royal

   Original Article 24 August 2010 Pages: 1757 - 1769

   

2. Evaluation of the immunogenicity of a single chain chimeric peptide composed of hCGβ and oLHα for inhibition of the growth of hCGβ-expressing cancer cells

   • Chu Jiang
   • Yahong Jiang
   • Qingxiang Shen

   Original Article 31 August 2010 Pages: 1771 - 1779

   

3. A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer

   • Eleni G. Iliopoulou
   • Panteleimon Kountourakis
   • Sonia A. Perez

   Original Article 12 August 2010 Pages: 1781 - 1789

   

4. A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi-scid, IL-2Rγ^null mouse lymphoma model

   • Fumihiko Sato
   • Asahi Ito
   • Ryuzo Ueda

   Original Article 17 August 2010 Pages: 1791 - 1800

   

5. Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model

   • Julia Pinkhasov
   • M. Lucrecia Alvarez
   • Pinku Mukherjee

   Original Article 08 September 2010 Pages: 1801 - 1811

   

6. Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancer

   • Alain G. Zeimet
   • Daniel Reimer
   • Christian Marth

   Original Article 18 August 2010 Pages: 1813 - 1823

   

7. Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes

   • Marvin M. van Luijn
   • Martine E. D. Chamuleau
   • S. Marieke van Ham

   Original Article Open access 05 September 2010 Pages: 1825 - 1838

   

8. In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors

   • Céline Berthon
   • Virginie Driss
   • Bruno Quesnel

   Original Article Open access 04 September 2010 Pages: 1839 - 1849

   

9. Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer

   • Bangwei Cao
   • Linzhong Zhu
   • Shutian Zhang

   Original Article 02 September 2010 Pages: 1851 - 1857

   

10. Immunization with a recombinant GnRH vaccine fused to heat shock protein 65 inhibits mammary tumor growth in vivo

    • Xue Jun Wang
    • Kai Gu
    • Jing Jing Liu

    Original Article 28 August 2010 Pages: 1859 - 1866

    

11. Viral DNA contamination is responsible for Epstein–Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein–Barr virus B-lymphoblastoid cell line

    • Mathilde Berthomé
    • Géraldine Gallot
    • Henri Vié

    Original Article 31 August 2010 Pages: 1867 - 1875

    

12. Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers

    • Melissa A. Geller
    • Sarah Cooley
    • Jeffrey S. Miller

    Original Article 05 September 2010 Pages: 1877 - 1884

    

13. Inhibition of metastasis of syngeneic murine melanoma in vivo and vasculogenesis in vitro by monoclonal antibody C11C1 targeted to domain 5 of high molecular weight kininogen

    • Sabina T. Khan
    • Robin A. Pixley
    • Robert W. Colman

    Original Article 02 September 2010 Pages: 1885 - 1893

    

14. Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1–3 October 2009

    • Michele Maio
    • Hugues J. M. Nicolay
    • NIBIT

    Meeting Report 05 March 2010 Pages: 1895 - 1901